Literature DB >> 9806188

Growth inhibition of prostate cell lines in vitro by phyto-oestrogens.

J Hempstock1, J P Kavanagh, N J George.   

Abstract

OBJECTIVE: To assess a range of phyto-oestrogens as moderators of growth and metabolism in several prostate cell lines.
MATERIALS AND METHODS: Four prostate cell lines (PNT-1/A, PNT-2, PC-3 and DU145) were challenged with different doses of five phyto-oestrogens (biochanin A, daidzein, genistein, genistin and nordihydroguaiaretic acid) over 3 days in culture. Cell proliferation was assessed by incorporation of 5-bromo-2'-deoxyuridine (BrdU) and metabolic activity by cleavage of a tetrazolium salt (XTT).
RESULTS: Growth and metabolism were inhibited with all compounds and cell lines (e.g. the dose for 50% inhibition of proliferation of PC-3 cells by genistein was 38 micromol/L); differences in the patterns of results suggested that different mechanisms operated, but there was no evidence for any synergistic activity on the inhibition of cell proliferation.
CONCLUSION: These results offer further support for the hypothesized role of phyto-oestrogens as dietary protectors against prostatic cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806188     DOI: 10.1046/j.1464-410x.1998.00769.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  12 in total

1.  Effect of combination treatment of rapamycin and isoflavones on mTOR pathway in human glioblastoma (U87) cells.

Authors:  Shilpa Puli; Aditi Jain; James C K Lai; Alok Bhushan
Journal:  Neurochem Res       Date:  2010-02-23       Impact factor: 3.996

Review 2.  Vitamin D metabolism and action in the prostate: implications for health and disease.

Authors:  Srilatha Swami; Aruna V Krishnan; David Feldman
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

3.  A role for estrogen receptor beta in the regulation of growth of the ventral prostate.

Authors:  Z Weihua; S Makela; L C Andersson; S Salmi; S Saji; J I Webster; E V Jensen; S Nilsson; M Warner; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

4.  Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones.

Authors:  Shilpa Puli; James C K Lai; Alok Bhushan
Journal:  J Neurooncol       Date:  2006-04-06       Impact factor: 4.130

5.  A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancer.

Authors:  Nagi B Kumar; Jeffrey P Krischer; Kathy Allen; Diane Riccardi; Karen Besterman-Dahan; Raoul Salup; Lovellen Kang; Ping Xu; Julio Pow-Sang
Journal:  Nutr Cancer       Date:  2007       Impact factor: 2.900

Review 6.  [A critical assessment of phytotherapy for prostate cancer].

Authors:  F G E Perabo; E C von Löw; R Siener; J Ellinger; S C Müller; P J Bastian
Journal:  Urologe A       Date:  2009-03       Impact factor: 0.639

7.  Suppressive effects of dietary genistin and daidzin on rat prostate carcinogenesis.

Authors:  K Kato; S Takahashi; L Cui; T Toda; S Suzuki; M Futakuchi; S Sugiura; T Shirai
Journal:  Jpn J Cancer Res       Date:  2000-08

Review 8.  Radiosensitization in prostate cancer: mechanisms and targets.

Authors:  Diego A Palacios; Makito Miyake; Charles J Rosser
Journal:  BMC Urol       Date:  2013-01-26       Impact factor: 2.264

9.  Enhancement of the activity of phenoxodiol by cisplatin in prostate cancer cells.

Authors:  R A C McPherson; P T Galettis; P L de Souza
Journal:  Br J Cancer       Date:  2009-02-10       Impact factor: 7.640

10.  Estrogen receptor (α and β) but not androgen receptor expression is correlated with recurrence, progression and survival in post prostatectomy T3N0M0 locally advanced prostate cancer in an urban Greek population.

Authors:  Georgios Megas; Michael Chrisofos; Ioannis Anastasiou; Aida Tsitlidou; Theodosia Choreftaki; Charalampos Deliveliotis
Journal:  Asian J Androl       Date:  2015 Jan-Feb       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.